Exploring the components and impact of social prescribing
Exploring the components and impact of social prescribing
复制标题
DOI：
10.1108/jpmh-06-2014-0027
复制
发表时间：
2015-01-01
影响因子：
1.4
通讯作者：
O'Cathain, Alicia
中科院分区：
文献类型：
--
作者：
Kilgarriff-Foster, Alexis;O'Cathain, Alicia
目的-社会处方是短期的中介服务，促进有心理社会需求的患者参与非临床支持。然而，很少有人知道社会处方的组成部分和潜在的影响。本文旨在讨论这个问题。设计/方法/方式-进行了审查，以探索证据的基础上，社会处方，包括映射其关键组成部分和潜在的影响。利用数据库、互联网和手工检索来识别相关研究。数据提取和叙述分析进行了探讨的issues.Findings -在总数，24项研究符合纳入标准。这些研究的方法和所评价的服务各不相同。全科医生和患者等利益相关者认为，社会处方增加了患者的心理健康和减少卫生服务的使用。然而，支持这一点的定量证据有限。唯一的随机对照试验显示，在四个月内症状减少，功能健康增加。其他非对照设计有很大的辍学率限制其价值在determiningefficient.Research限制/影响-需要进一步研究的有效性和成本效益的社会处方使用强大的评价designs.Originality/值-这是第一次审查的通用社会处方服务的重点放在一般的证据基础。
Purpose - Social prescribing are short-term intermediary services that facilitate patients with psychosocial needs to engage in non-clinical support. However, little is known about the components and potential impact of social prescribing. The paper aims to discuss this issue.Design/methodology/approach - A review was conducted to explore the evidence based on social prescribing including mapping its key components and potential impact. Database, internet and hand searching was utilised to identify relevant studies. Data extraction and narrative analysis was undertaken to explore the issues.Findings - In total, 24 studies met the inclusion criteria. The studies were diverse in their methodologies and the services evaluated. Stakeholders such as general practitioners and patients perceived that social prescribing increased patients' mental well-being and decreased health service use. However, the quantitative evidence supporting this was limited. The only randomised-controlled trial showed a decrease in symptoms and increase in functional well-being at four months. The other non-controlled designs had large drop-out rates limiting their value in determining effectiveness.Research limitations/implications - Further research is needed on the effectiveness and cost-effectiveness of social prescribing using robust evaluative designs.Originality/value - This is the first review of generic social prescribing services focusing on the general evidence base.